Lost power this morning ...so missed the early morning dip...seems to have rebounded...looks like it wants to hit new highs.
Question is...is it worth the shot now with this run or wait for better pricing ?
Have to thank WSJ and others on avita. Looks like long term big opportunity. Not sure if BARDA and cytori will ever pan out now.only cat are scleroderma maybe and urology use. Hope they can get good stability data for cancer drug. That means 2.5 catalysts left..to monday